nodes	percent_of_prediction	percent_of_DWPC	metapath
Sodium stibogluconate—Intestinal perforation—Vandetanib—thyroid cancer	0.044	0.0459	CcSEcCtD
Sodium stibogluconate—Cellulitis—Vandetanib—thyroid cancer	0.0191	0.0199	CcSEcCtD
Sodium stibogluconate—Hypocalcaemia—Vandetanib—thyroid cancer	0.019	0.0198	CcSEcCtD
Sodium stibogluconate—Creatinine increased—Vandetanib—thyroid cancer	0.0183	0.0191	CcSEcCtD
Sodium stibogluconate—Faecaloma—Epirubicin—thyroid cancer	0.0152	0.0158	CcSEcCtD
Sodium stibogluconate—Faecalith—Epirubicin—thyroid cancer	0.0152	0.0158	CcSEcCtD
Sodium stibogluconate—Sepsis—Vandetanib—thyroid cancer	0.0151	0.0157	CcSEcCtD
Sodium stibogluconate—TOP1—saliva-secreting gland—thyroid cancer	0.0148	0.362	CbGeAlD
Sodium stibogluconate—Faecaloma—Doxorubicin—thyroid cancer	0.014	0.0146	CcSEcCtD
Sodium stibogluconate—Faecalith—Doxorubicin—thyroid cancer	0.014	0.0146	CcSEcCtD
Sodium stibogluconate—Warmth—Epirubicin—thyroid cancer	0.0136	0.0142	CcSEcCtD
Sodium stibogluconate—Hypocalcaemia—Sorafenib—thyroid cancer	0.0128	0.0134	CcSEcCtD
Sodium stibogluconate—Hyperphosphataemia—Epirubicin—thyroid cancer	0.0127	0.0132	CcSEcCtD
Sodium stibogluconate—Hyponatraemia—Vandetanib—thyroid cancer	0.0127	0.0132	CcSEcCtD
Sodium stibogluconate—Warmth—Doxorubicin—thyroid cancer	0.0126	0.0132	CcSEcCtD
Sodium stibogluconate—Blood creatinine increased—Vandetanib—thyroid cancer	0.0118	0.0123	CcSEcCtD
Sodium stibogluconate—Hyperphosphataemia—Doxorubicin—thyroid cancer	0.0117	0.0122	CcSEcCtD
Sodium stibogluconate—Dehydration—Vandetanib—thyroid cancer	0.0117	0.0122	CcSEcCtD
Sodium stibogluconate—Hypokalaemia—Vandetanib—thyroid cancer	0.0115	0.012	CcSEcCtD
Sodium stibogluconate—TOP1—trachea—thyroid cancer	0.0114	0.279	CbGeAlD
Sodium stibogluconate—Dysphagia—Vandetanib—thyroid cancer	0.0109	0.0114	CcSEcCtD
Sodium stibogluconate—Bronchospasm—Vandetanib—thyroid cancer	0.0107	0.0112	CcSEcCtD
Sodium stibogluconate—Bronchitis—Vandetanib—thyroid cancer	0.0105	0.0109	CcSEcCtD
Sodium stibogluconate—Renal failure—Vandetanib—thyroid cancer	0.00957	0.00997	CcSEcCtD
Sodium stibogluconate—Cardiac failure congestive—Sorafenib—thyroid cancer	0.00939	0.00979	CcSEcCtD
Sodium stibogluconate—Renal failure acute—Sorafenib—thyroid cancer	0.00923	0.00962	CcSEcCtD
Sodium stibogluconate—TOP1—thyroid gland—thyroid cancer	0.00904	0.221	CbGeAlD
Sodium stibogluconate—Hyponatraemia—Sorafenib—thyroid cancer	0.00855	0.00892	CcSEcCtD
Sodium stibogluconate—Hypernatraemia—Epirubicin—thyroid cancer	0.00825	0.0086	CcSEcCtD
Sodium stibogluconate—Venous thrombosis—Epirubicin—thyroid cancer	0.00804	0.00838	CcSEcCtD
Sodium stibogluconate—Dehydration—Sorafenib—thyroid cancer	0.00792	0.00826	CcSEcCtD
Sodium stibogluconate—Arrhythmia—Vandetanib—thyroid cancer	0.0078	0.00814	CcSEcCtD
Sodium stibogluconate—Hypokalaemia—Sorafenib—thyroid cancer	0.00775	0.00808	CcSEcCtD
Sodium stibogluconate—Hypernatraemia—Doxorubicin—thyroid cancer	0.00763	0.00796	CcSEcCtD
Sodium stibogluconate—Dysgeusia—Vandetanib—thyroid cancer	0.00745	0.00777	CcSEcCtD
Sodium stibogluconate—Venous thrombosis—Doxorubicin—thyroid cancer	0.00743	0.00775	CcSEcCtD
Sodium stibogluconate—Dysphagia—Sorafenib—thyroid cancer	0.00736	0.00768	CcSEcCtD
Sodium stibogluconate—Vision blurred—Vandetanib—thyroid cancer	0.00717	0.00747	CcSEcCtD
Sodium stibogluconate—Loss of consciousness—Vandetanib—thyroid cancer	0.00668	0.00697	CcSEcCtD
Sodium stibogluconate—Convulsion—Vandetanib—thyroid cancer	0.00659	0.00687	CcSEcCtD
Sodium stibogluconate—Chest pain—Vandetanib—thyroid cancer	0.00647	0.00675	CcSEcCtD
Sodium stibogluconate—Acute coronary syndrome—Sorafenib—thyroid cancer	0.00647	0.00675	CcSEcCtD
Sodium stibogluconate—Renal failure—Sorafenib—thyroid cancer	0.00645	0.00673	CcSEcCtD
Sodium stibogluconate—Anxiety—Vandetanib—thyroid cancer	0.00645	0.00673	CcSEcCtD
Sodium stibogluconate—Myocardial infarction—Sorafenib—thyroid cancer	0.00644	0.00671	CcSEcCtD
Sodium stibogluconate—Oedema—Vandetanib—thyroid cancer	0.00621	0.00647	CcSEcCtD
Sodium stibogluconate—Infection—Vandetanib—thyroid cancer	0.00617	0.00643	CcSEcCtD
Sodium stibogluconate—Lung disorder—Epirubicin—thyroid cancer	0.00613	0.00639	CcSEcCtD
Sodium stibogluconate—Lung disorder—Doxorubicin—thyroid cancer	0.00567	0.00591	CcSEcCtD
Sodium stibogluconate—TOP1—lymph node—thyroid cancer	0.00561	0.137	CbGeAlD
Sodium stibogluconate—Paraesthesia—Vandetanib—thyroid cancer	0.00557	0.00581	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Vandetanib—thyroid cancer	0.00553	0.00577	CcSEcCtD
Sodium stibogluconate—Feeling hot—Epirubicin—thyroid cancer	0.00553	0.00576	CcSEcCtD
Sodium stibogluconate—Necrosis—Epirubicin—thyroid cancer	0.00553	0.00576	CcSEcCtD
Sodium stibogluconate—Abscess—Epirubicin—thyroid cancer	0.00548	0.00572	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Vandetanib—thyroid cancer	0.0054	0.00563	CcSEcCtD
Sodium stibogluconate—Fatigue—Vandetanib—thyroid cancer	0.00535	0.00558	CcSEcCtD
Sodium stibogluconate—Constipation—Vandetanib—thyroid cancer	0.00531	0.00553	CcSEcCtD
Sodium stibogluconate—Arrhythmia—Sorafenib—thyroid cancer	0.00526	0.00549	CcSEcCtD
Sodium stibogluconate—Necrosis—Doxorubicin—thyroid cancer	0.00511	0.00533	CcSEcCtD
Sodium stibogluconate—Feeling hot—Doxorubicin—thyroid cancer	0.00511	0.00533	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00508	0.00529	CcSEcCtD
Sodium stibogluconate—Abscess—Doxorubicin—thyroid cancer	0.00507	0.00529	CcSEcCtD
Sodium stibogluconate—Dysgeusia—Sorafenib—thyroid cancer	0.00502	0.00524	CcSEcCtD
Sodium stibogluconate—Extravasation—Epirubicin—thyroid cancer	0.00497	0.00518	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Vandetanib—thyroid cancer	0.00491	0.00512	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Vandetanib—thyroid cancer	0.00491	0.00512	CcSEcCtD
Sodium stibogluconate—Cellulitis—Epirubicin—thyroid cancer	0.00477	0.00497	CcSEcCtD
Sodium stibogluconate—Hypocalcaemia—Epirubicin—thyroid cancer	0.00474	0.00494	CcSEcCtD
Sodium stibogluconate—Oliguria—Epirubicin—thyroid cancer	0.00471	0.00491	CcSEcCtD
Sodium stibogluconate—Syncope—Sorafenib—thyroid cancer	0.0046	0.0048	CcSEcCtD
Sodium stibogluconate—Extravasation—Doxorubicin—thyroid cancer	0.0046	0.0048	CcSEcCtD
Sodium stibogluconate—Ulcer—Epirubicin—thyroid cancer	0.00459	0.00478	CcSEcCtD
Sodium stibogluconate—Creatinine increased—Epirubicin—thyroid cancer	0.00456	0.00475	CcSEcCtD
Sodium stibogluconate—Loss of consciousness—Sorafenib—thyroid cancer	0.00451	0.0047	CcSEcCtD
Sodium stibogluconate—Asthenia—Vandetanib—thyroid cancer	0.00445	0.00464	CcSEcCtD
Sodium stibogluconate—Cellulitis—Doxorubicin—thyroid cancer	0.00441	0.0046	CcSEcCtD
Sodium stibogluconate—Pruritus—Vandetanib—thyroid cancer	0.00439	0.00458	CcSEcCtD
Sodium stibogluconate—Hypocalcaemia—Doxorubicin—thyroid cancer	0.00438	0.00457	CcSEcCtD
Sodium stibogluconate—Oliguria—Doxorubicin—thyroid cancer	0.00435	0.00454	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Vandetanib—thyroid cancer	0.00425	0.00443	CcSEcCtD
Sodium stibogluconate—Ulcer—Doxorubicin—thyroid cancer	0.00424	0.00442	CcSEcCtD
Sodium stibogluconate—Creatinine increased—Doxorubicin—thyroid cancer	0.00422	0.0044	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Sorafenib—thyroid cancer	0.00419	0.00437	CcSEcCtD
Sodium stibogluconate—Infection—Sorafenib—thyroid cancer	0.00416	0.00434	CcSEcCtD
Sodium stibogluconate—Shock—Sorafenib—thyroid cancer	0.00412	0.0043	CcSEcCtD
Sodium stibogluconate—Fluid retention—Epirubicin—thyroid cancer	0.00412	0.00429	CcSEcCtD
Sodium stibogluconate—Dizziness—Vandetanib—thyroid cancer	0.0041	0.00428	CcSEcCtD
Sodium stibogluconate—Blood urea increased—Epirubicin—thyroid cancer	0.00409	0.00427	CcSEcCtD
Sodium stibogluconate—Anorexia—Sorafenib—thyroid cancer	0.00399	0.00416	CcSEcCtD
Sodium stibogluconate—Vomiting—Vandetanib—thyroid cancer	0.00395	0.00411	CcSEcCtD
Sodium stibogluconate—Rash—Vandetanib—thyroid cancer	0.00391	0.00408	CcSEcCtD
Sodium stibogluconate—Dermatitis—Vandetanib—thyroid cancer	0.00391	0.00408	CcSEcCtD
Sodium stibogluconate—Headache—Vandetanib—thyroid cancer	0.00389	0.00405	CcSEcCtD
Sodium stibogluconate—Fluid retention—Doxorubicin—thyroid cancer	0.00381	0.00397	CcSEcCtD
Sodium stibogluconate—Blood urea increased—Doxorubicin—thyroid cancer	0.00379	0.00395	CcSEcCtD
Sodium stibogluconate—Sepsis—Epirubicin—thyroid cancer	0.00376	0.00392	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Sorafenib—thyroid cancer	0.00373	0.00389	CcSEcCtD
Sodium stibogluconate—Nausea—Vandetanib—thyroid cancer	0.00369	0.00384	CcSEcCtD
Sodium stibogluconate—Phlebitis—Epirubicin—thyroid cancer	0.00365	0.00381	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Sorafenib—thyroid cancer	0.00364	0.00379	CcSEcCtD
Sodium stibogluconate—Fatigue—Sorafenib—thyroid cancer	0.00361	0.00376	CcSEcCtD
Sodium stibogluconate—Constipation—Sorafenib—thyroid cancer	0.00358	0.00373	CcSEcCtD
Sodium stibogluconate—Sepsis—Doxorubicin—thyroid cancer	0.00348	0.00363	CcSEcCtD
Sodium stibogluconate—Cardiac failure congestive—Epirubicin—thyroid cancer	0.00347	0.00362	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00342	0.00357	CcSEcCtD
Sodium stibogluconate—Renal failure acute—Epirubicin—thyroid cancer	0.00341	0.00356	CcSEcCtD
Sodium stibogluconate—Phlebitis—Doxorubicin—thyroid cancer	0.00338	0.00353	CcSEcCtD
Sodium stibogluconate—Urticaria—Sorafenib—thyroid cancer	0.00333	0.00347	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Sorafenib—thyroid cancer	0.00331	0.00345	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Sorafenib—thyroid cancer	0.00331	0.00345	CcSEcCtD
Sodium stibogluconate—Renal impairment—Epirubicin—thyroid cancer	0.00331	0.00345	CcSEcCtD
Sodium stibogluconate—Cerebrovascular accident—Epirubicin—thyroid cancer	0.00321	0.00335	CcSEcCtD
Sodium stibogluconate—Cardiac failure congestive—Doxorubicin—thyroid cancer	0.00321	0.00335	CcSEcCtD
Sodium stibogluconate—Hyponatraemia—Epirubicin—thyroid cancer	0.00316	0.0033	CcSEcCtD
Sodium stibogluconate—Renal failure acute—Doxorubicin—thyroid cancer	0.00316	0.00329	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Sorafenib—thyroid cancer	0.00308	0.00322	CcSEcCtD
Sodium stibogluconate—Renal impairment—Doxorubicin—thyroid cancer	0.00306	0.00319	CcSEcCtD
Sodium stibogluconate—Asthenia—Sorafenib—thyroid cancer	0.003	0.00313	CcSEcCtD
Sodium stibogluconate—Cerebrovascular accident—Doxorubicin—thyroid cancer	0.00297	0.0031	CcSEcCtD
Sodium stibogluconate—Pruritus—Sorafenib—thyroid cancer	0.00296	0.00309	CcSEcCtD
Sodium stibogluconate—Blood creatinine increased—Epirubicin—thyroid cancer	0.00295	0.00308	CcSEcCtD
Sodium stibogluconate—Dehydration—Epirubicin—thyroid cancer	0.00293	0.00305	CcSEcCtD
Sodium stibogluconate—Hyponatraemia—Doxorubicin—thyroid cancer	0.00292	0.00305	CcSEcCtD
Sodium stibogluconate—Hypokalaemia—Epirubicin—thyroid cancer	0.00287	0.00299	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Sorafenib—thyroid cancer	0.00286	0.00299	CcSEcCtD
Sodium stibogluconate—Dizziness—Sorafenib—thyroid cancer	0.00277	0.00289	CcSEcCtD
Sodium stibogluconate—Abdominal distension—Epirubicin—thyroid cancer	0.00274	0.00286	CcSEcCtD
Sodium stibogluconate—Blood creatinine increased—Doxorubicin—thyroid cancer	0.00273	0.00285	CcSEcCtD
Sodium stibogluconate—Dysphagia—Epirubicin—thyroid cancer	0.00272	0.00284	CcSEcCtD
Sodium stibogluconate—Dehydration—Doxorubicin—thyroid cancer	0.00271	0.00282	CcSEcCtD
Sodium stibogluconate—Vomiting—Sorafenib—thyroid cancer	0.00266	0.00278	CcSEcCtD
Sodium stibogluconate—Hypokalaemia—Doxorubicin—thyroid cancer	0.00265	0.00276	CcSEcCtD
Sodium stibogluconate—Rash—Sorafenib—thyroid cancer	0.00264	0.00275	CcSEcCtD
Sodium stibogluconate—Dermatitis—Sorafenib—thyroid cancer	0.00264	0.00275	CcSEcCtD
Sodium stibogluconate—Headache—Sorafenib—thyroid cancer	0.00262	0.00273	CcSEcCtD
Sodium stibogluconate—Bronchitis—Epirubicin—thyroid cancer	0.00262	0.00273	CcSEcCtD
Sodium stibogluconate—Abdominal distension—Doxorubicin—thyroid cancer	0.00253	0.00264	CcSEcCtD
Sodium stibogluconate—Dysphagia—Doxorubicin—thyroid cancer	0.00252	0.00263	CcSEcCtD
Sodium stibogluconate—Nausea—Sorafenib—thyroid cancer	0.00249	0.00259	CcSEcCtD
Sodium stibogluconate—Bronchitis—Doxorubicin—thyroid cancer	0.00242	0.00252	CcSEcCtD
Sodium stibogluconate—Renal failure—Epirubicin—thyroid cancer	0.00238	0.00249	CcSEcCtD
Sodium stibogluconate—Renal failure—Doxorubicin—thyroid cancer	0.00221	0.0023	CcSEcCtD
Sodium stibogluconate—Hypoaesthesia—Epirubicin—thyroid cancer	0.00217	0.00226	CcSEcCtD
Sodium stibogluconate—Hypoaesthesia—Doxorubicin—thyroid cancer	0.00201	0.00209	CcSEcCtD
Sodium stibogluconate—Arrhythmia—Epirubicin—thyroid cancer	0.00195	0.00203	CcSEcCtD
Sodium stibogluconate—Flatulence—Epirubicin—thyroid cancer	0.00187	0.00195	CcSEcCtD
Sodium stibogluconate—Dysgeusia—Epirubicin—thyroid cancer	0.00186	0.00194	CcSEcCtD
Sodium stibogluconate—Arrhythmia—Doxorubicin—thyroid cancer	0.0018	0.00188	CcSEcCtD
Sodium stibogluconate—Vision blurred—Epirubicin—thyroid cancer	0.00179	0.00186	CcSEcCtD
Sodium stibogluconate—Flatulence—Doxorubicin—thyroid cancer	0.00173	0.0018	CcSEcCtD
Sodium stibogluconate—Dysgeusia—Doxorubicin—thyroid cancer	0.00172	0.00179	CcSEcCtD
Sodium stibogluconate—Syncope—Epirubicin—thyroid cancer	0.0017	0.00177	CcSEcCtD
Sodium stibogluconate—Palpitations—Epirubicin—thyroid cancer	0.00168	0.00175	CcSEcCtD
Sodium stibogluconate—Loss of consciousness—Epirubicin—thyroid cancer	0.00167	0.00174	CcSEcCtD
Sodium stibogluconate—Vision blurred—Doxorubicin—thyroid cancer	0.00165	0.00172	CcSEcCtD
Sodium stibogluconate—Convulsion—Epirubicin—thyroid cancer	0.00164	0.00171	CcSEcCtD
Sodium stibogluconate—Chest pain—Epirubicin—thyroid cancer	0.00161	0.00168	CcSEcCtD
Sodium stibogluconate—Anxiety—Epirubicin—thyroid cancer	0.00161	0.00168	CcSEcCtD
Sodium stibogluconate—Syncope—Doxorubicin—thyroid cancer	0.00157	0.00164	CcSEcCtD
Sodium stibogluconate—Palpitations—Doxorubicin—thyroid cancer	0.00155	0.00162	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Epirubicin—thyroid cancer	0.00155	0.00161	CcSEcCtD
Sodium stibogluconate—Oedema—Epirubicin—thyroid cancer	0.00155	0.00161	CcSEcCtD
Sodium stibogluconate—Loss of consciousness—Doxorubicin—thyroid cancer	0.00154	0.00161	CcSEcCtD
Sodium stibogluconate—Infection—Epirubicin—thyroid cancer	0.00154	0.0016	CcSEcCtD
Sodium stibogluconate—Shock—Epirubicin—thyroid cancer	0.00152	0.00159	CcSEcCtD
Sodium stibogluconate—Convulsion—Doxorubicin—thyroid cancer	0.00152	0.00158	CcSEcCtD
Sodium stibogluconate—Tachycardia—Epirubicin—thyroid cancer	0.00151	0.00157	CcSEcCtD
Sodium stibogluconate—Hyperhidrosis—Epirubicin—thyroid cancer	0.0015	0.00156	CcSEcCtD
Sodium stibogluconate—Chest pain—Doxorubicin—thyroid cancer	0.00149	0.00156	CcSEcCtD
Sodium stibogluconate—Anxiety—Doxorubicin—thyroid cancer	0.00149	0.00155	CcSEcCtD
Sodium stibogluconate—Anorexia—Epirubicin—thyroid cancer	0.00148	0.00154	CcSEcCtD
Sodium stibogluconate—Hypotension—Epirubicin—thyroid cancer	0.00145	0.00151	CcSEcCtD
Sodium stibogluconate—Oedema—Doxorubicin—thyroid cancer	0.00143	0.00149	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Doxorubicin—thyroid cancer	0.00143	0.00149	CcSEcCtD
Sodium stibogluconate—Infection—Doxorubicin—thyroid cancer	0.00142	0.00148	CcSEcCtD
Sodium stibogluconate—Shock—Doxorubicin—thyroid cancer	0.00141	0.00147	CcSEcCtD
Sodium stibogluconate—Tachycardia—Doxorubicin—thyroid cancer	0.0014	0.00146	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Epirubicin—thyroid cancer	0.00139	0.00145	CcSEcCtD
Sodium stibogluconate—Hyperhidrosis—Doxorubicin—thyroid cancer	0.00138	0.00144	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Epirubicin—thyroid cancer	0.00138	0.00144	CcSEcCtD
Sodium stibogluconate—Anorexia—Doxorubicin—thyroid cancer	0.00136	0.00142	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Epirubicin—thyroid cancer	0.00135	0.0014	CcSEcCtD
Sodium stibogluconate—Hypotension—Doxorubicin—thyroid cancer	0.00134	0.00139	CcSEcCtD
Sodium stibogluconate—Fatigue—Epirubicin—thyroid cancer	0.00133	0.00139	CcSEcCtD
Sodium stibogluconate—Constipation—Epirubicin—thyroid cancer	0.00132	0.00138	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Doxorubicin—thyroid cancer	0.00129	0.00134	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Doxorubicin—thyroid cancer	0.00128	0.00133	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Epirubicin—thyroid cancer	0.00127	0.00132	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Doxorubicin—thyroid cancer	0.00124	0.0013	CcSEcCtD
Sodium stibogluconate—Fatigue—Doxorubicin—thyroid cancer	0.00123	0.00129	CcSEcCtD
Sodium stibogluconate—Urticaria—Epirubicin—thyroid cancer	0.00123	0.00128	CcSEcCtD
Sodium stibogluconate—Constipation—Doxorubicin—thyroid cancer	0.00122	0.00128	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Epirubicin—thyroid cancer	0.00122	0.00128	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Epirubicin—thyroid cancer	0.00122	0.00128	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.00117	0.00122	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Epirubicin—thyroid cancer	0.00114	0.00119	CcSEcCtD
Sodium stibogluconate—Urticaria—Doxorubicin—thyroid cancer	0.00114	0.00119	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Doxorubicin—thyroid cancer	0.00113	0.00118	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Doxorubicin—thyroid cancer	0.00113	0.00118	CcSEcCtD
Sodium stibogluconate—Asthenia—Epirubicin—thyroid cancer	0.00111	0.00116	CcSEcCtD
Sodium stibogluconate—Pruritus—Epirubicin—thyroid cancer	0.00109	0.00114	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Epirubicin—thyroid cancer	0.00106	0.0011	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Doxorubicin—thyroid cancer	0.00105	0.0011	CcSEcCtD
Sodium stibogluconate—Asthenia—Doxorubicin—thyroid cancer	0.00103	0.00107	CcSEcCtD
Sodium stibogluconate—Dizziness—Epirubicin—thyroid cancer	0.00102	0.00107	CcSEcCtD
Sodium stibogluconate—Pruritus—Doxorubicin—thyroid cancer	0.00101	0.00106	CcSEcCtD
Sodium stibogluconate—Vomiting—Epirubicin—thyroid cancer	0.000984	0.00103	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Doxorubicin—thyroid cancer	0.00098	0.00102	CcSEcCtD
Sodium stibogluconate—Rash—Epirubicin—thyroid cancer	0.000976	0.00102	CcSEcCtD
Sodium stibogluconate—Dermatitis—Epirubicin—thyroid cancer	0.000975	0.00102	CcSEcCtD
Sodium stibogluconate—Headache—Epirubicin—thyroid cancer	0.000969	0.00101	CcSEcCtD
Sodium stibogluconate—Dizziness—Doxorubicin—thyroid cancer	0.000947	0.000987	CcSEcCtD
Sodium stibogluconate—Nausea—Epirubicin—thyroid cancer	0.000919	0.000958	CcSEcCtD
Sodium stibogluconate—Vomiting—Doxorubicin—thyroid cancer	0.00091	0.000949	CcSEcCtD
Sodium stibogluconate—Rash—Doxorubicin—thyroid cancer	0.000903	0.000941	CcSEcCtD
Sodium stibogluconate—Dermatitis—Doxorubicin—thyroid cancer	0.000902	0.00094	CcSEcCtD
Sodium stibogluconate—Headache—Doxorubicin—thyroid cancer	0.000897	0.000935	CcSEcCtD
Sodium stibogluconate—Nausea—Doxorubicin—thyroid cancer	0.00085	0.000887	CcSEcCtD
